Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma Journal:Therapeutic Advances in Medical Oncology | 2019 | 80 | ||
2021 | 25 |